<HTML>
<HEAD>
<TITLE>Prepared and filed by St Ives Financials</TITLE>
</HEAD>
<body bgcolor="#ffffff" style='font-family:"Times New Roman"'>

<page>


<div style="border:none;border-bottom:solid .05em;padding:0in 0in 1.0pt 0in">
<div style=" border:none;border-bottom:solid .25em;padding:0in 0in 1.0pt 0in"><p></p></div></div><BR>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><B><font style='font-size:16 PT'>UNITED STATES</font></B></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><B><font style='font-size:16 PT'>SECURITIES AND EXCHANGE COMMISSION</font></B></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><b><font style='font-size:12pt'>Washington, D.C. 20549</font></b></p>

<p style=' margin-bottom:0pt; margin-top:12pt;text-align:center;'><B><font style='font-size:16 PT'>FORM 8-K</font></B></p>

<p style=' margin-bottom:0pt; margin-top:12pt;text-align:center;'><B><font style='font-size:10 PT'>CURRENT REPORT</font></B></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><b><font style='font-size:10 pt'>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</font></b></p>

<p style=' margin-bottom:0pt; margin-top:12pt;text-align:center;'><font style='font-size:10 pt'>Date
  of report (Date of earliest event reported): November 2, 2006</font></p>

<p style=' margin-bottom:0pt; margin-top:8pt;text-align:center;'><b><font style='font-size:18 pt'>Impax
  Laboratories, Inc.</font></b></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font style='font-size:10 pt'>(Exact
  name of registrant as specified in its charter)</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font style='font-size:10 pt'>&nbsp;</font></p>

<table width="100%" cellspacing=0 cellpadding=0>
    <tr>
        <td width="50">&nbsp;</td>
                    <td align=center valign=top width="280"><b><font style='font-size:10 pt'>Delaware</font></b><br>
<font style='font-size:10 pt'>(State or other jurisdiction</font><br>
<font style='font-size:10 pt'>of incorporation)</font><br></td>
        <td align=center valign=top width="280"><b><font style='font-size:10 pt'>0-27354</font></b><br>
            <font style='font-size:10 pt'>(Commission</font><br>
<font style='font-size:10 pt'>File Number)</font><br></td>
        <td align=center valign=top width="280"><b><font style='font-size:10 pt'>65-0403311</font></b><br>
            <font style='font-size:10 pt'>(I.R.S. Employer</font><br>
<font style='font-size:10 pt'>Identification No.)</font><br></td>
        <td width="50">&nbsp;</td></tr></table>

<p style=' margin-bottom:0pt; margin-top:12pt;text-align:center;'><b><font style='font-size:11 pt'>30831 Huntwood Ave., Hayward, CA 94544</font></b></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font style='font-size:11 pt'>(Address of principal executive offices) (Zip Code)</font></p>

<p style=' margin-bottom:0pt; margin-top:12pt;text-align:center;'><b><font style='font-size:10 pt'>510-476-2000</font></b></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font style='font-size:10 pt'>(Registrant&#146;s telephone number, including area code)  </font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font style='font-size:10 pt'>&nbsp;</font></p>

<p style=' margin-bottom:0pt; margin-top:12pt;text-align:center;'><b><font style='font-size:10 pt'>Not
  Applicable</font></b></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font style='font-size:10 pt'>(Former name or former address, if changed since last report)</font></p>

<p style=' margin-bottom:0pt; margin-top:8pt;text-align:left;'><font style='font-size:10 pt'>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</font></p>


<div align=left>


  <table border="0" cellspacing=0 cellpadding=0 width="90%" style=' border-collapse:collapse;'>
    <tr>
      <td width="6%" valign=top style='padding:8.0pt 0in 0in 0in;'>&nbsp;</td>
      <td width="6%" valign=top style='padding:8.0pt 0in 0in 0in;'><font style='font-size:12 pt'><img src="emptybox.gif" width="12" height="12"></font></td>
      <td width="87%" valign=top style='padding:8.0pt 0in 0in 0in;'><font style='font-size:10 pt'>Written
        communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></td>
    </tr>
    <tr>
      <td width="6%" valign=top style='padding:8.0pt 0in 0in 0in;'>
        <p style=' margin-left:0pt;text-indent:0pt;text-align:left;margin-top:8pt;margin-bottom:0pt;'><font size=1>&nbsp;</font></p>
      </td>
      <td width="6%" valign=top style='padding:8.0pt 0in 0in 0in;'>
        <p style=' margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt;'><font style='font-size:12 pt'><img src="emptybox.gif" width="12" height="12"><br>
          </font></p>
      </td>
      <td width="87%" valign=top style='padding:8.0pt 0in 0in 0in;'>
        <p style=' margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt;'><font style='font-size:10 pt'>Soliciting
          material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></p>
      </td>
    </tr>
    <tr>
      <td width="6%" valign=top style='padding:8.0pt 0in 0in 0in;'>&nbsp;</td>
      <td width="6%" valign=top style='padding:8.0pt 0in 0in 0in;'><font style='font-size:12 pt'><img src="emptybox.gif" width="12" height="12"><br>
        </font></td>
      <td width="87%" valign=top style='padding:8.0pt 0in 0in 0in;'><font style='font-size:10 pt'>&nbsp;Pre-commencement
        communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
        240.14d-2(b))</font></td>
    </tr>
    <tr>
      <td width="6%" valign=top style='padding:8.0pt 0in 0in 0in;'>&nbsp;</td>
      <td width="6%" valign=top style='padding:8.0pt 0in 0in 0in;'><font style='font-size:12 pt'><img src="emptybox.gif" width="12" height="12"><br>
        </font></td>
      <td width="87%" valign=top style='padding:8.0pt 0in 0in 0in;'><font style='font-size:10 pt'>&nbsp;Pre-commencement
        communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
        240.13e-4(c))</font></td>
    </tr>
  </table>
</div>

<div style='border:none;border-bottom:solid .25em;padding:0in 0in 1.0pt 0in'>

<div style='border:none;border-bottom:solid .05em;padding:0in 0in 1.0pt 0in'>
<p></p> </div> </div> <BR>



<div align=left> </div>

<p align="center"><Font size="2" face="serif"></font></p>
<hr noshade align="center" width="100%" size="2">
<div style="page-break-before:always"></div><page>


<p style=' margin-bottom:0pt; margin-top:12pt;text-align:left;'><b><font style='font-size:10 pt'>Item 7.01 Regulation FD Disclosure</font></b></p>

<p style=' margin-bottom:0pt; margin-top:8pt; margin-left:5%;text-align:left;'><font style='font-size:10 pt'>From time to time, management of the Company prepares investor presentation materials for use at investor conferences and/or for distribution to interested persons and posts the presentation materials to the Company&#146;s website. A copy of recently prepared presentation materials is attached hereto as Exhibit 99.1 and is incorporated herein by reference. A copy of this information is being  posted to the Company&#146;s website at www.impaxlabs.com. This information shall not be deemed &#147;filed&#148; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this report, irrespective of any </font><font style='font-size:11 pt'>general incorporation
language in such filing.</font></p>


<div align=left>


<table border="0" cellspacing=0 cellpadding=0 width="44%" style=' border-collapse:collapse;'>
    <tr>

        <td width="22%" valign=top style='padding:12.0pt 0in 0in 0in;'>

<p style=' margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt;'><b><font style='font-size:10 pt'>Item 9.01</font></b><font style='font-size:10 pt'>&nbsp;&nbsp;</font></p> </td>

        <td width="77%" valign=top style='padding:12.0pt 0in 0in 0in;'>

<p style=' margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt;'><b><font style='font-size:10 pt'>Financial Statements and Exhibits.</font></b></p> </td> </tr></table>
</div>



<p style=' margin-bottom:0pt; margin-top:8pt; margin-left:15%;text-align:left;'><font style='font-size:10 pt'>(d) Exhibits.</font></p>

<p style=' margin-bottom:0pt; margin-top:8pt; margin-left:20%;text-align:left;'><font style='font-size:10 pt'>99.1 - Presentation Materials dated November 2006.</font></p>

<p style=' margin-bottom:0pt; margin-top:16pt;text-align:center;'><B><font style='font-size:10 PT'>EXHIBIT INDEX</font></B></p>


<div align=left>


<table border="0" cellspacing=0 cellpadding=0 width="100%" style=' border-collapse:collapse;'>
    <tr>

        <td width="14%" valign=bottom style='padding:0in 5.4pt 0in 5.4pt;'>

        <p style=' margin-left:0pt;text-indent:0pt;text-align:center;margin-top:2pt;margin-bottom:0pt;'><u><b><font style='font-size:8 pt'>Exhibit
          No</font></b></u><u>.</u></p>
      </td>

        <td valign=bottom style='padding:0in 5.4pt 0in 5.4pt;'>

<p style=' margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt;'><u><b><font style='font-size:8 pt'>Description</font></b></u><u></u></p> </td> </tr>

    <tr style='height:.05in;'>

        <td valign=top style='padding:0in 5.4pt 0in 5.4pt; height:.05in;'>

<p style=' margin-left:0pt;text-indent:0pt;text-align:center;margin-top:2pt;margin-bottom:0pt;'><font size=1>&nbsp;</font></p> </td>

        <td valign=top style='padding:0in 5.4pt 0in 5.4pt; height:.05in;'>

<p style=' margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt;'><font size=1>&nbsp;</font></p> </td> </tr>
    <tr>

        <td valign=top style='padding:0in 5.4pt 0in 5.4pt;'>

<p style=' margin-left:0pt;text-indent:0pt;text-align:center;margin-top:2pt;margin-bottom:0pt;'><font style='font-size:10 pt'>99.1</font></p> </td>

        <td valign=top style='padding:0in 5.4pt 0in 5.4pt;'>

<p style=' margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt;'><font style='font-size:10 pt'>Presentation Materials dated November 2006</font></p> </td> </tr>

    <tr style='height:.05in;'>

        <td valign=top style='padding:0in 5.4pt 0in 5.4pt; height:.05in;'>

<p style=' margin-left:0pt;text-indent:0pt;text-align:center;margin-top:2pt;margin-bottom:0pt;'><font size=1>&nbsp;</font></p> </td>

        <td valign=top style='padding:0in 5.4pt 0in 5.4pt; height:.05in;'>

<p style=' margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt;'><font size=1>&nbsp;</font></p> </td> </tr></table>
</div>





<p align="center"><Font size="2" face="serif"></font></p>

<hr noshade align="center" width="100%" size="2">

<div style="page-break-before:always"></div><page>



<p style=' margin-bottom:0pt; margin-top:16pt;text-align:center;'><B><font style='font-size:10 PT'>SIGNATURES</font></B></p>

<p style=' margin-bottom:0pt; margin-top:8pt; text-indent:5%;text-align:left;'><font style='font-size:10 pt'>Pursuant
  to the requirements of the Securities Exchange Act of 1934, the registrant has
  duly caused this report to be signed on its behalf by the undersigned hereunto
  duly authorized.</font></p>

<p style=' margin-bottom:0pt; margin-top:8pt;text-align:left;'><font style='font-size:10 pt'>Dated:
  November 2, 2006</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font style='font-size:10 pt'>&nbsp;</font></p>


<div align=center>


<table border="0" cellspacing=0 cellpadding=0 width="100%" style=' border-collapse:collapse;'>
    <tr>

        <td colspan="2" valign=bottom >&nbsp;</td>

        <td width="1%" valign=bottom >

<p style=' margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0in;margin-bottom:0pt;'><font size=1>&nbsp;</font></p> </td>

        <td colspan="2" valign=bottom ><p style=' margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0in;margin-bottom:0pt;'><font style='font-size:11 PT'>IMPAX</font><font style='font-size:10 pt'> </font><font style='font-size:11 PT'>LABORATORIES</font><font style='font-size:10 pt'>, </font><font style='font-size:11 PT'>INC</font><font style='font-size:10 pt'>.</font></p></td>
    </tr>
    <tr>

        <td width="6%" valign=bottom >&nbsp;</td>

        <td width="43%" valign=bottom >&nbsp;</td>

        <td width="1%" valign=bottom >

<p style=' margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0in;margin-bottom:0pt;'><font size=1>&nbsp;</font></p> </td>

        <td width="6%" valign=bottom ><p style=' margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0in;margin-bottom:0pt;'><font style='font-size:10 pt'>By:&nbsp;</font></p></td>
        <td width="43%" valign=bottom ><p style=' margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0in;margin-bottom:0pt;'><br>
                <font style='font-size:11 pt'>/s/ Arthur A. Koch, Jr.</font></p></td>
    </tr>
    <tr>

        <td valign=top >&nbsp;</td>

        <td valign=top >&nbsp;</td>

        <td valign=top >

<p style=' margin-left:0pt;text-indent:0pt;text-align:left;margin-bottom:0pt;'><font size=1>&nbsp;</font></p> </td>

        <td valign=top ><p style=' margin-left:0pt;text-indent:0pt;text-align:left;margin-bottom:0pt;'><font size=1>&nbsp;</font></p></td>
        <td valign=top ><p style=' margin-left:0pt;text-indent:0pt;text-align:left;margin-bottom:0pt;'>
            <hr noshade width="100%" color="Gray" size="1">
        </td>
    </tr>
    <tr>

        <td valign=top >&nbsp;</td>

        <td valign=top >&nbsp;</td>

        <td valign=top >

<p style=' margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0in;margin-bottom:0pt;'><font size=1>&nbsp;</font></p> </td>

        <td valign=top ><p style=' margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0in;margin-bottom:0pt;'><font style='font-size:10 pt'>Name:&nbsp;</font></p></td>
        <td valign=top ><p style=' margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0in;margin-bottom:0pt;'><font style='font-size:11 pt'>Arthur A. Koch, Jr.</font></p></td>
    </tr>
    <tr>

        <td valign=top >&nbsp;</td>

        <td valign=top >&nbsp;</td>

        <td valign=top >

<p style=' margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0in;margin-bottom:0pt;'><font size=1>&nbsp;</font></p> </td>

        <td valign=top ><p style=' margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0in;margin-bottom:0pt;'><font style='font-size:10 pt'>Title:&nbsp;</font></p></td>
        <td valign=top ><p style=' margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0in;margin-bottom:0pt;'><font style='font-size:11 pt'>Chief Financial Officer</font></p></td>
  </tr></table>
</div>







<p align="center"><Font size="2" face="serif">2</font></p>

<hr noshade align="center" width="100%" size="2">

</body>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "b415511_8k.htm", "description": "FORM 8-K", "secsgml_size_bytes": 15379}]
{"company-data": {"conformed-name": "IMPAX LABORATORIES INC", "cik": "0001003642", "assigned-sic": "2834", "irs-number": "650403311", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-27354", "film-number": "061182940"}, "business-address": {"street1": "30831 HAYWARD AVE", "city": "HAYWARD", "state": "CA", "zip": "94544", "phone": "2152892220"}, "mail-address": {"street1": "CASTOR & KENSINGTON AVENUES", "city": "PHILADELPHIA", "state": "PA", "zip": "19124-5694"}, "former-company": {"former-conformed-name": "GLOBAL PHARMACEUTICAL CORP \\DE\\", "date-changed": "19951117"}}
Prepared and filed by St Ives Financials
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
  of report (Date of earliest event reported): November 2, 2006
Impax
  Laboratories, Inc.
(Exact
  name of registrant as specified in its charter)
Delaware
(State or other jurisdiction
of incorporation)
0-27354
(Commission
File Number)
65-0403311
(I.R.S. Employer
Identification No.)
30831 Huntwood Ave., Hayward, CA 94544
(Address of principal executive offices) (Zip Code)
510-476-2000
(Registrant's telephone number, including area code)
Not
  Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written
        communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting
          material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement
        communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
        240.14d-2(b))
Pre-commencement
        communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
        240.13e-4(c))
Item 7.01 Regulation FD Disclosure
From time to time, management of the Company prepares investor presentation materials for use at investor conferences and/or for distribution to interested persons and posts the presentation materials to the Company's website. A copy of recently prepared presentation materials is attached hereto as Exhibit 99.1 and is incorporated herein by reference. A copy of this information is being  posted to the Company's website at www.impaxlabs.com. This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this report, irrespective of any
general incorporation
language in such filing.
Item 9.01
Financial Statements and Exhibits.
(d) Exhibits.
99.1 - Presentation Materials dated November 2006.
EXHIBIT INDEX
Exhibit
          No
.
Description
99.1
Presentation Materials dated November 2006
SIGNATURES
Pursuant
  to the requirements of the Securities Exchange Act of 1934, the registrant has
  duly caused this report to be signed on its behalf by the undersigned hereunto
  duly authorized.
Dated:
  November 2, 2006
IMPAX
LABORATORIES
,
INC
.
By:
/s/ Arthur A. Koch, Jr.
Name:
Arthur A. Koch, Jr.
Title:
Chief Financial Officer
2